A combination anti-diabetic medication used to treat Type 2 diabetes by controlling blood sugar levels.

Glimepiride stimulates insulin release from the pancreas, while Metformin improves insulin sensitivity and reduces liver glucose production.

This oral, often sustained-release medication is taken with meals to manage glycemic control alongside diet and exercise.

Enhanced Blood Sugar Control: Combines two mechanisms to lower blood glucose more efficiently than monotherapy. Glimepiride stimulates insulin secretion, while Metformin decreases liver glucose production and increases insulin sensitivity.

Reduced Complications: Effective glycemic management with this combination helps prevent long-term diabetic complications, including kidney damage and heart issues.

Comprehensive Management: Targets both fasting sugar levels and postprandial (after-meal) sugar levels.

A combination anti-diabetic medication used to treat Type 2 diabetes by controlling blood sugar levels.

Glimepiride stimulates insulin release from the pancreas, while Metformin improves insulin sensitivity and reduces liver glucose production.

This oral, often sustained-release medication is taken with meals to manage glycemic control alongside diet and exercise.

Enhanced Blood Sugar Control: Combines two mechanisms to lower blood glucose more efficiently than monotherapy. Glimepiride stimulates insulin secretion, while Metformin decreases liver glucose production and increases insulin sensitivity.

Reduced Complications: Effective glycemic management with this combination helps prevent long-term diabetic complications, including kidney damage and heart issues.

Comprehensive Management: Targets both fasting sugar levels and postprandial (after-meal) sugar levels.